Literature DB >> 31724288

Annual banned-substance review - Analytical approaches in human sports drug testing.

Mario Thevis1,2, Tiia Kuuranne3, Hans Geyer1,2.   

Abstract

Within the complex construct of today's antidoping work, continuously updated routine doping controls, as well as advancements in sampling and analysis have been of particular relevance and importance. New analytes of existing classes of prohibited substances are frequently included into sports drug testing assays, analytical approaches are optimized to allow for better sensitivities, selectivity, and/or faster turnaround times, and research dedicated to addressing analytical issues concerning scenarios of both (potentially) inadvertent doping and new emerging doping agents is constantly conducted. By way of reviewing and summarizing, this annual banned-substance review evaluates the literature published between October 2018 and September 2019 offering an in-depth evaluation of developments in these arenas and their potential application to substances reported in WADA's 2019 Prohibited List.
© 2019 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.

Entities:  

Keywords:  alternative matrices; doping; mass spectrometry; sport

Year:  2020        PMID: 31724288     DOI: 10.1002/dta.2735

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  2 in total

Review 1.  Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches.

Authors:  Lukáš Huml; Jan Tauchen; Silvie Rimpelová; Barbora Holubová; Oldřich Lapčík; Michal Jurášek
Journal:  Sensors (Basel)       Date:  2021-12-21       Impact factor: 3.576

2.  Investigations into the In Vitro Metabolism of hGH and IGF-I Employing Stable-Isotope-Labelled Drugs and Monitoring Diagnostic Immonium Ions by High-Resolution/High-Accuracy Mass Spectrometry.

Authors:  Sophia Krombholz; Andreas Thomas; Mario Thevis
Journal:  Metabolites       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.